Latest News

Flaw in Alzheimer's drug trial test, research suggests

New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Common antidepressant may change brain differently in depressed and non-depressed people

  • Extra hour of screen time per day associated with poorer GCSE grades

  • How protein tangles accumulate in brain, cause neurological disorders

  • Artificial intelligence authors crowdsourced interactive fiction

  • Neighbors, but not classmates

  • IV administration of endothelin B receptor drug reduces memory loss, oxidative stress in Alzheimer's disease

  • Highly effective seasickness treatment on the horizon

  • Making effective use of voluntary help

  • Tracking down the causes of Alzheimer's

  • New model of cognitive flexibility gives insight into autism spectrum disorder

  •